Hims stock price reacts strongly to crucial FDA review
Hims & Hers (HIMS) has caught a powerful new tailwind, and the market is treating peptides as mo[……] Read More
Hims & Hers shifts business model after Novo deal
Hims & Hers (HIMS) has taken a beating, with the stock down roughly 70% from its $70 peak and no[……]…